All public logs
Jump to navigation
Jump to search
Combined display of all available logs of Wikibase.slis.ua.edu. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)- 21:46, 19 May 2020 Maintenance script talk contribs created page Section 3.3.5: Cancer-associated MSCs and CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 21:46, 19 May 2020 Maintenance script talk contribs created page Section 3.3.4: Cancer-associated fibroblasts and CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 21:46, 19 May 2020 Maintenance script talk contribs created page Section 3.3.3: Tumor-associated macrophages and CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 21:46, 19 May 2020 Maintenance script talk contribs created page Section 3.3.2: The hypoxia microenvironment and CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 21:46, 19 May 2020 Maintenance script talk contribs created page Section 3.3.1: Vascular niche microenvironments and CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 21:46, 19 May 2020 Maintenance script talk contribs created page Section 3.3: The microenvironment of CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 21:46, 19 May 2020 Maintenance script talk contribs created page Section 3.2.9: Interactions between signaling pathways in CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 21:46, 19 May 2020 Maintenance script talk contribs created page Section 3.2.8: PPAR signaling pathways in CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 21:46, 19 May 2020 Maintenance script talk contribs created page Section 3.2.7PI3K/AKT/mTOR signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 21:46, 19 May 2020 Maintenance script talk contribs created page Section 3.2.6: TGF/SMAD signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 21:46, 19 May 2020 Maintenance script talk contribs created page Section 3.2.5: JAK-STAT signaling pathway (from DOI: 10.1038/s41392-020-0110-5)
- 21:46, 19 May 2020 Maintenance script talk contribs created page Section 3.2.4: NF-kappaB signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 21:46, 19 May 2020 Maintenance script talk contribs created page Section 3.2.3: Hh signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 21:46, 19 May 2020 Maintenance script talk contribs created page Section 3.2.2: Notch signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 21:46, 19 May 2020 Maintenance script talk contribs created page Section 3.2.1: Wnt signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 21:46, 19 May 2020 Maintenance script talk contribs created page Section 3.2: Major signaling pathways in CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 21:46, 19 May 2020 Maintenance script talk contribs created page Section 3.1: Major transcription factors in CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 21:46, 19 May 2020 Maintenance script talk contribs created page Section 3: Factors regulating CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 21:46, 19 May 2020 Maintenance script talk contribs created page Section 2.2: Isolation and identification of CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 21:46, 19 May 2020 Maintenance script talk contribs created page Section 2.1: Biological characteristics of CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 21:46, 19 May 2020 Maintenance script talk contribs created page Section 2: The concept of CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 15:29, 19 May 2020 Maintenance script talk contribs created page Hongjuan Cui (11th author of 10.1038/s41392-020-0110-5)
- 15:29, 19 May 2020 Maintenance script talk contribs created page Fei Chen (10th author of 10.1038/s41392-020-0110-5)
- 15:29, 19 May 2020 Maintenance script talk contribs created page Zhen Dong (9th author of 10.1038/s41392-020-0110-5)
- 15:29, 19 May 2020 Maintenance script talk contribs created page Xiaowen Wang (8th author of 10.1038/s41392-020-0110-5)
- 15:29, 19 May 2020 Maintenance script talk contribs created page Guanghui Zhang (7th author of 10.1038/s41392-020-0110-5)
- 15:29, 19 May 2020 Maintenance script talk contribs created page Jiayi Zhang (6th author of 10.1038/s41392-020-0110-5)
- 15:29, 19 May 2020 Maintenance script talk contribs created page Wen Peng (5th author of 10.1038/s41392-020-0110-5)
- 15:29, 19 May 2020 Maintenance script talk contribs created page Jie Xu (4th author of 10.1038/s41392-020-0110-5)
- 15:29, 19 May 2020 Maintenance script talk contribs created page Gaichao Zhao (3rd author of 10.1038/s41392-020-0110-5)
- 15:29, 19 May 2020 Maintenance script talk contribs created page Pengfei Shi (2nd author of 10.1038/s41392-020-0110-5)
- 12:16, 17 May 2020 Maintenance script talk contribs created page Hemming VG., et al, Clin Diagn Lab Immunol (2001) cited as Ref 7 in DOI: 10.1080/22221751.2020.1735265
- 12:16, 17 May 2020 Maintenance script talk contribs created page Mori I, et al, PLoS One (2008) cited as Ref 6 in DOI: 10.1080/22221751.2020.1735265
- 12:16, 17 May 2020 Maintenance script talk contribs created page Taoran G, et al, Chin J Internal Med (2020) cited as Ref 5 in DOI: 10.1080/22221751.2020.1735265
- 12:16, 17 May 2020 Maintenance script talk contribs created page Tai-sheng LI, et al, Chin J Lab Med (2003) cited as Ref 4 in DOI: 10.1080/22221751.2020.1735265
- 12:16, 17 May 2020 Maintenance script talk contribs created page Li T, et al, Chin Med J (Engl) (2003) cited as Ref 3 in DOI: 10.1080/22221751.2020.1735265
- 12:16, 17 May 2020 Maintenance script talk contribs created page World Health Organization cited as Ref 2 in DOI: 10.1080/22221751.2020.1735265
- 19:05, 14 May 2020 Maintenance script talk contribs created page Disclosure statement (from DOI: 10.1080/22221751.2020.1735265)
- 19:05, 14 May 2020 Maintenance script talk contribs created page Section 5: Criteria of isolation release and discharge (from DOI: 10.1080/22221751.2020.1735265)
- 19:05, 14 May 2020 Maintenance script talk contribs created page Section 4: Protection and transfer (from DOI: 10.1080/22221751.2020.1735265)
- 19:05, 14 May 2020 Maintenance script talk contribs created page Section 3.5.6: Empirical antimicrobial therapy (from DOI: 10.1080/22221751.2020.1735265)
- 19:05, 14 May 2020 Maintenance script talk contribs created page Section 3.5.5: Intravenous immunoglobulin (from DOI: 10.1080/22221751.2020.1735265)
- 19:05, 14 May 2020 Maintenance script talk contribs created page Section 3.5.4: Glucocorticoid therapy (from DOI: 10.1080/22221751.2020.1735265)
- 19:05, 14 May 2020 Maintenance script talk contribs created page Section 3.5.3: Antiviral treatment (from DOI: 10.1080/22221751.2020.1735265)
- 19:05, 14 May 2020 Maintenance script talk contribs created page Section 3.5.2.2: The way of respiratory support (from DOI: 10.1080/22221751.2020.1735265)
- 19:05, 14 May 2020 Maintenance script talk contribs created page Section 3.5.2.1: Choice of oxygen therapy (from DOI: 10.1080/22221751.2020.1735265)
- 19:05, 14 May 2020 Maintenance script talk contribs created page Section 3.5.2: Oxygen therapy (from DOI: 10.1080/22221751.2020.1735265)
- 19:05, 14 May 2020 Maintenance script talk contribs created page Section 3.5.1: General treatment (from DOI: 10.1080/22221751.2020.1735265)
- 19:05, 14 May 2020 Maintenance script talk contribs created page Section 3.5: Treatment (from DOI: 10.1080/22221751.2020.1735265)
- 19:05, 14 May 2020 Maintenance script talk contribs created page Section 3.4.2: Critically ill type (from DOI: 10.1080/22221751.2020.1735265)